News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR Logo
Biological markers identified as powerful predictors of prostate cancer relapse following radiotherapy

04/04/23

Two key proteins linked to cell division can reliably predict disease recurrence in prostate cancer after radiotherapy treatment, according to new research.
The International Space Station. Credit: public domain / NASA
Cancer cells set to be launched into space for microgravity experiment on the International Space Station

24/03/23

A pioneering UK research project to study the three-dimensional spread of cancer cells in microgravity is set to take place on the International Space Station.
Myeloma cells producing monoclonal proteins of varying types
Genetic test can guide treatment for blood cancer to help prevent relapse

19/03/23

Scientists have found a new way to predict which patients with the blood cancer myeloma will benefit the most from a treatment often used to help keep the disease from coming back after a bone marrow transplant.
MR linac 537 x 410
New scan measures tumour oxygen levels in real-time to help guide treatment

16/03/23

Imaging researchers have taken a major step towards their ultimate goal of identifying cancers that are starved of oxygen so that altered treatment can be used to target them more effectively.
Single prostate cancer cell grown in culture
Over a decade of abiraterone: the drug that revolutionised advanced prostate cancer care

14/03/23

This Prostate Cancer Awareness Month, we’re celebrating over 10 years since abiraterone was first recommended by NICE in England as a treatment for advanced prostate cancer. We share the story of the drug’s discovery, how a landmark trial changed the way advanced prostate cancer is treated today, and what the drug has meant for patients who are currently treated with it.
icr-team-with-chris-in-lab_landscape-low-res-547x410
Charity funding could help establish new clinical trials for deadliest of all childhood cancers

14/03/23

The Institute of Cancer Research, London has been awarded £2.5 million by the charity Brain Tumour Research to help find new treatments and pave the way towards a cure for the childhood cancer high grade glioma, a type of brain tumour.
breast cancer cell 547 x 383
Scientists discover a new way to help prevent breast cancer ‘time bomb’

13/03/23

Scientists have discovered why breast cancer cells that have spread to the lungs may ‘wake up’ following years of sleep - forming incurable secondary tumours.
T cell_547x410
Algorithm offers new way to spot patients likely to respond to immunotherapy

09/03/23

Scientists have developed a new way of using cancers’ DNA to spot cancer patients who may benefit from immunotherapy.
DNA Array news sidebar
Gene test could guide use of cancer chemotherapy

02/03/23

A gene test already used routinely in the NHS can guide use of chemotherapy in people with bowel cancer by predicting whether or not they will benefit.
DNA double helix - computer visualisation
New study unveils epigenetic ‘traffic lights’ controlling stop and go for gene activity

01/03/23

A major new study in the journal Nature reveals a ‘traffic light’ mechanism controlling genetic activity within cells – a system which could potentially be targeted by cancer drugs already in development.
ICR Logo
Expectations for population-wide gene testing need to be realistic, say researchers

01/03/23

Testing a population for multiple genes at once will always be limited in its ability to accurately predict disease risk, experts are warning.
Human DIPG cells (orange) grown on a mouse brain 'slice' (light blue), treated with the drug combination, trametinib and dasatinib and showing cells dying in the middle.
Scientists reveal how different cancer cells ‘team up’ to help incurable childhood brain tumour spread

27/02/23

Scientists have shed light on how different types of cancer cells in an aggressive childhood brain cancer interact and work together to spread.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.